Partnering conferences are an essential part of the business development activities in the life science industry. Our premium match-making system HelloPartnering lets conference participants plan and schedule their meetings in advance. What sets HelloPartnering apart is that data about assets and companies is populated from Biotechgate, meaning: No more “empty” company profiles in a conference … Continue reading Partnering and match-making system with data from Biotechgate
Spanish Life Sciences Trend Analysis 2019
2018 was a booming year in Spanish biotech thanks to 77 USD mln of venture capital invested in the industry during this period. Two main financings rounds were scored by Catalan biopharma companies – Minoryx Therapeutics and Abac Therapeutics and the third one by AlgaEnergy – a Madrid based company specialized in microalgae technology. Download … Continue reading Spanish Life Sciences Trend Analysis 2019
Dutch Life Sciences Trend Analysis 2019
With about 500 biotech companies registered, The Netherlands remain one of the strongest Life Science markets in Europe. The number of biotechs newly founded in 2018 was not as high as in previous years but the region is very far from stagnation. According to the data gathered in Biotechgate, over 100 million USD of venture … Continue reading Dutch Life Sciences Trend Analysis 2019
Search options for “intervention type” and “drug name” are now available in clinical trial section
Zurich, 29th May 2019 The clinical trial section in Biotechgate has received a new feature: it is now possible to search the clinical trial database for the type of intervention you are interested in (e.g. drug, diagnostic test or device). In addition, the option to search for specific drugs, devices, etc. has been implemented, with … Continue reading Search options for “intervention type” and “drug name” are now available in clinical trial section
Swiss Life Sciences Trend Analysis 2019
2018 was another very active year in the Swiss life sciences industry. The report compiled using the data from Biotechgate shows that the biotech financing was only slightly lower than in the record in 2017, while the total value of investments for the whole life science industry was even higher than in the previous year. … Continue reading Swiss Life Sciences Trend Analysis 2019
The Biotechgate Categorization System Explained
The life science industry is highly complex, and categorizing its players is a challenging task. When we created Biotechgate, a global life science database, we needed to formulate a system that would reflect the state of the industry as accurately as possible while remaining intuitive to users. There are eleven sectors in the Biotechgate database, … Continue reading The Biotechgate Categorization System Explained
UK Life Sciences Trend Analysis 2019
The United Kingdom is the largest European market when it comes to the number of life science companies. There are over 1,200 biotech companies based there with the total number of about 900 biopharmaceutical products being currently developed. 2018 was the record year in terms of the level of financing – 1,777 million USD was … Continue reading UK Life Sciences Trend Analysis 2019
Biotechgate announces the launch of a clinical trial database
Zurich, 25th March 2019 Biotechgate announces the launch of a clinical trial database with more than 460,000 trial records. Clinical trial data is imported from more than 13 registries around the world and continuously updated and catalogued. Thanks to the use of newly developed smart software components, the data is presented in a well-structured and … Continue reading Biotechgate announces the launch of a clinical trial database
New clinical trials and license agreements section
In March 2019 we will launch the beta versions of two new components for Biotechgate: Clinical trials information and a new license agreement section. More than 450,000 clinical trials will be available in Biotechgate and more than 100’000 of them will be linked to existing company profiles in the database. In addition, a completely newly … Continue reading New clinical trials and license agreements section
Site Selection Report for Life Sciences Companies in Europe 2018
The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018